We Found a Tiny Float Gem to Report On New report coming at market open tomorrow 7/30/20 Good day everyone, The Covid 19 pandemic is still a major iss...
FDA Approves Xeglyze (abametapir) Lotion for the Treatment of Head Lice
Article Link: FDA Approves Xeglyze (abametapir) Lotion for the Treatment of Head Lice HYDERABAD, India & PRINCETON, N.J.–(BUSIN...
FDA Approves Tecartus (brexucabtagene autoleucel) as the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma
Article Link: FDA Approves Tecartus (brexucabtagene autoleucel) as the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma&...
FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) for the Maintenance Treatment of COPD
Article Link: FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) for the Maintenance Treatment of COPD 24 Ju...
FDA Approves Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
Article Link: FDA Approves Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Cataplexy or Excessive Daytime Sleepiness Asso...
FDA Approves Wynzora Cream (calcipotriene and betamethasone dipropionate) for Adults with Plaque Psoriasis
Article Link: FDA Approves Wynzora Cream (calcipotriene and betamethasone dipropionate) for Adults with Plaque Psoriasis COPENHAGEN, Denm...
FDA Approves Wynzora Cream (calcipotriene and betamethasone dipropionate w/w 0.005%/0.064%) for Adults with Plaque Psoriasis
Article Link: FDA Approves Wynzora Cream (calcipotriene and betamethasone dipropionate w/w 0.005%/0.064%) for Adults with Plaque Psoriasis ...
Averitas Pharma Announces FDA Approval of Qutenza for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy of the Feet
Article Link: Averitas Pharma Announces FDA Approval of Qutenza for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy o...
Genprex (GNPX), Cancer, Diabetes and Gene Therapy Genprex is now part of the Russell 3000
Good day everyone, We are initiating coverage of Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company involved in developing various ap...
Does Vuzix (VUZI) Have the Next Product in Disruptive Technology?
Traders News Source Feature Report: Does Vuzix (VUZI) Have the Next Product in Disruptive Technology?